Category:Dan Burton: Difference between revisions
Jump to navigation
Jump to search
Dr Robotnik (talk | contribs) No edit summary |
Dr Robotnik (talk | contribs) No edit summary |
||
| Line 83: | Line 83: | ||
| |
| |
||
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]] |
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]] |
||
|- style="vertical-align: top; background:#F5F4F2" |
|||
|2015 3rd Quarter |
|||
|style="text-align:right;"|$30000 |
|||
|[[:Category:US Senate|US Senate]] |
|||
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852224 300852224] |
|||
|[[:Category:Dan Burton|Dan Burton International LLC]] |
|||
|[[:Category:CCHR|CCHR]] |
|||
|[[:Category:Dan Burton|Dan Burton]] |
|||
| |
|||
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act and it its Senate counterpart (not yet introduced). |
|||
|- style="vertical-align: top; background:#F5F4F2" |
|- style="vertical-align: top; background:#F5F4F2" |
||
|2015 4th Quarter |
|2015 4th Quarter |
||
| Line 103: | Line 93: | ||
| |
| |
||
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]] |
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]] |
||
|- style="vertical-align: top; background:#F5F4F2" |
|||
|2015 4th Quarter |
|||
|style="text-align:right;"|$30000 |
|||
|[[:Category:US Senate|US Senate]] |
|||
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852220 300852220] |
|||
|[[:Category:Dan Burton|Dan Burton International LLC]] |
|||
|[[:Category:CCHR|CCHR]] |
|||
|[[:Category:Dan Burton|Dan Burton]] |
|||
| |
|||
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act and it its Senate counterpart (not yet introduced). |
|||
|- style="vertical-align: top; background:#F5F4F2" |
|- style="vertical-align: top; background:#F5F4F2" |
||
|2016 1st Quarter |
|2016 1st Quarter |
||
| Line 128: | Line 108: | ||
*[[:Category:2016|2016]], [[:Category:Mental Health Reform Act of 2016|Mental Health Reform Act of 2016]] |
*[[:Category:2016|2016]], [[:Category:Mental Health Reform Act of 2016|Mental Health Reform Act of 2016]] |
||
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]] |
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]] |
||
|- style="vertical-align: top; background:#F5F4F2" |
|||
|2016 1st Quarter |
|||
|style="text-align:right;"|$20000 |
|||
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]] |
|||
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300815526 300815526] |
|||
|[[:Category:Dan Burton|Dan Burton International LLC]] |
|||
|[[:Category:CCHR|CCHR]] |
|||
|[[:Category:Dan Burton|Dan Burton]] |
|||
| |
|||
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act, in H. R. 2646 - Helping Families in Mental Health Crisis and in S. 1077 - Advancing Breakthrough Devices For Patients Act of 2015. |
|||
* |
|||
*Opposition to FDA Proposed Rule on electroconvulsive therapy (ECT) devices. |
|||
|- style="vertical-align: top; background:#F5F4F2" |
|||
|2016 1st Quarter |
|||
|style="text-align:right;"|$30000 |
|||
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]] |
|||
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852217 300852217] |
|||
|[[:Category:Dan Burton|Dan Burton International LLC]] |
|||
|[[:Category:CCHR|CCHR]] |
|||
|[[:Category:Dan Burton|Dan Burton]] |
|||
| |
|||
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act, in H. R. 2646 - Helping Families in Mental Health Crisis and in S. 1077 - Advancing Breakthrough Devices For Patients Act of 2015. |
|||
* |
|||
*Opposition to FDA Proposed Rule on electroconvulsive therapy (ECT) devices. |
|||
|- style="vertical-align: top; background:#F5F4F2" |
|- style="vertical-align: top; background:#F5F4F2" |
||
|2016 2nd Quarter |
|2016 2nd Quarter |
||
| Line 167: | Line 123: | ||
*[[:Category:2016|2016]], [[:Category:Mental Health Reform Act of 2016|Mental Health Reform Act of 2016]] |
*[[:Category:2016|2016]], [[:Category:Mental Health Reform Act of 2016|Mental Health Reform Act of 2016]] |
||
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]] |
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]] |
||
|- style="vertical-align: top; background:#F5F4F2" |
|||
|2016 2nd Quarter |
|||
|style="text-align:right;"|$30000 |
|||
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]] |
|||
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852213 300852213] |
|||
|[[:Category:Dan Burton|Dan Burton International LLC]] |
|||
|[[:Category:CCHR|CCHR]] |
|||
|[[:Category:Dan Burton|Dan Burton]] |
|||
| |
|||
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act, in House Appropriations Subcommittee Bill on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies for FY 2017 (containing provisions of H. R. 6), in H. R. 2646 - Helping Families in Mental Health Crisis in S. 1077 - Advancing Breakthrough Devices For Patients Act of 2015, in S. 2680 - Mental Health Reform Act of 2016 and in FDA Proposed Rule on Electroconvulsive Therapy (ECT). |
|||
|- style="vertical-align: top; background:#F5F4F2" |
|- style="vertical-align: top; background:#F5F4F2" |
||
|2016 3rd Quarter |
|2016 3rd Quarter |
||
| Line 192: | Line 138: | ||
*[[:Category:2016|2016]], [[:Category:Mental Health Reform Act of 2016|Mental Health Reform Act of 2016]] |
*[[:Category:2016|2016]], [[:Category:Mental Health Reform Act of 2016|Mental Health Reform Act of 2016]] |
||
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]] |
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]] |
||
|- style="vertical-align: top; background:#F5F4F2" |
|||
|2016 3rd Quarter |
|||
|style="text-align:right;"|$30000 |
|||
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]] |
|||
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852210 300852210] |
|||
|[[:Category:Dan Burton|Dan Burton International LLC]] |
|||
|[[:Category:CCHR|CCHR]] |
|||
|[[:Category:Dan Burton|Dan Burton]] |
|||
| |
|||
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act, in House Appropriations Subcommittee Bill on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies for FY 2017 (containing provisions of H. R. 6), in H. R. 2646 - Helping Families in Mental Health Crisis in S. 1077 - Advancing Breakthrough Devices For Patients Act of 2015, in S. 2680 - Mental Health Reform Act of 2016 and in FDA Proposed Rule on Electroconvulsive Therapy (ECT). |
|||
|- style="vertical-align: top; background:#F5F4F2" |
|- style="vertical-align: top; background:#F5F4F2" |
||
|2016 4th Quarter |
|2016 4th Quarter |
||
Revision as of 17:09, 19 May 2017
| Dan Burton | |
|---|---|
 | |
| Born |
Danny Lee Burton June 21, 1938 Indianapolis, Indiana |
| Residence | Indianapolis, Indiana |
| Alma mater | Cincinnati Christian University |
| Occupation | Lobbyist |
| Political party | Republican |
| Religion | Christian churches and churches of Christ |
| Spouse(s) |
|
| Formation | January 22, 2013 |
|---|---|
| Jurisdiction | us-in |
| Registration no. | 2013012400212 |
| Headquarters | 12141 E 79th ST, Indianapolis, IN, 46236, USA |
| Formation | May 5, 2011 |
|---|---|
| Jurisdiction | us-va |
| Registration no. | S3634203 |
Lobbyist activity
CCHR
See also
Dan Burton article from Wikipedia
External links
- Lobbying Spending Database-Dan Burton International, 2016, OpenSecrets.
- Lobbying Spending Database - Dan Burton International, 2016, OpenSecrets.
- Revolving Door: Dan Burton Employment Summary, OpenSecrets.
- Dan Burton's last antivaccine hurrah?, ScienceBlogs.
Subcategories
This category has the following 4 subcategories, out of 4 total.
Pages in category "Dan Burton"
The following 15 pages are in this category, out of 15 total.
C
F
L
S
Media in category "Dan Burton"
The following 2 files are in this category, out of 2 total.
Congres1.jpg 605 × 778; 166 KB
Congres2.jpg 592 × 772; 65 KB
